- Home
- >
- All Countries
- >
- USA
End to End Regulatory Partner in the USA
Artixio, with its team’s decades of experience in successfully registering and post market compliance maintenance for diverse lifesciences products across regulatory affairs, quality (GxP), market access in the USA.
Regulatory Authorities in the USA
Key bodies within FDA that regulate various lifesciences products include, Center for Devices and Radiological Health (CDRH) that Regulates companies that manufacture, import or market medical devices in the USA; Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) that is responsible for review and regulation of biopharmaceutical products; Center for Food Safety and Applied Nutrition (CFSAN) and Center for Veterinary Medicine
Pre-Registration
- Regulatory Intelligence
- Regulatory Strategy
- Market assessment
- Technical and medical writing
- Local Agent Appointment
- Document Review
- Risk Management
- Pre-submission to FDA
- Dossier Gap Analysis
- Technical Due Diligence
Registration services
- Product registration
- Dossier Preparation & Submission (IND, NDA, ANDA, BLA, 510k) to US FDA
- HA liaison and legal
- Medical and Technical Writing
- Labelling and Artwork
- ECTD/CTD preparation and submission
- Compliance check
- QMS, Mock Audits & Vendor Audits
- Pricing & Reimbursement
Post-Registration
- Compliance monitoring
- Post-marketing surveillance
- Product Recall Management
- Lifecycle Maintenance
- Change Management
- Advertisement & Promotional Material Review
- Importer/ Distributer Assistance
Our Services






Why Artixio?










Industries We Serve in the USA
FAQs
What are different submissions that you support in the USA?
Do you provide US Agent Services?
What are different post marketing services that you offer?
What are the quality compliance services and standards that you support?
Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

Europe

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea
Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in
Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

UK Releases Amendment &
In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

Artixio Announces Grant for
HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...